During the past decade, Click Therapeutics conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Click Therapeutics" are "Drug Addiction" (2 trials), "Drug Dependence" (2 trials), "Nicotine Addiction" (2 trials), "Substance Use Disorder" (2 trials) and "Tobacco Dependence" (2 trials). Many other conditions were trialed in "Click Therapeutics" in a lesser frequency.

Most popular intervention types in "Click Therapeutics" are "Device" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clickotine®" (1 trials), "DiNaMo Study App" (1 trials), "EMA + Automated Text Message Intervention" (1 trials), "EMA Alone" (1 trials) and "Mobile Smoking Cessation Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Click Therapeutics" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Click Therapeutics". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Click Therapeutics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Click Therapeutics, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".